Drug Trial Radar · NCT06634849
An Open Label Dose Finding Study of PTT-4256 in Patients With Solid Tumours (RAISIC-1).
Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Nov 4, 2024
Primary completion
Apr 30, 2027
Study completion Oct 30, 2027
Sponsor
- Lead sponsor
- Pathios Therapeutics Pty LtdIndustry
- Sponsor type
- Industry
- First posted
- Oct 10, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This open label, dose escalation module will evaluate the safety, tolerability, PK, PD, and preliminary efficacy of PTT-4256 in participants with solid tumours using a combination of accelerated dose titration (ADT) and Bayesian Optimal Interval (BOIN) design.
Conditions
- Advanced Solid Tumor
Interventions
PTT-4256Drug
Single oral intake of PTT-4256 followed by treatment-free period of 3 days to assess safety, PK and PD. After 72-hr post dose PK sample, first 21day cycle of once daily PTT-4256 will begin to assess DLTs. Cohorts A1-A5 will receive 10mg, 20mg, 40mg, 80mg \& 160mg. Following review by SRC, Cohort A6 participants will receive 300mg PTT-4256 daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with Treatment emergent adverse events (TEAEs), Adverse events and Serious Adverse events as assessed by CTCAE V5.0Time frame: First dose IMP to 21 to 28 days after last IMP dose.
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Blacktown Hospital
Blacktown, New South Wales, Australia · Recruiting
Scientia Clinical Research
Randwick, New South Wales, Australia · Recruiting
Southern Oncology Clinical Research Unit (SOCRU)
Adelaide, South Australia, Australia · Recruiting
Austin Health
Heidelberg, Victoria, Australia · Recruiting
Linear Clinical Research
Nedlands, Western Australia, Australia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.